SANTIS PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of SANTIS PHARMA is 1.7% (moderate). The 2025 annual accounts show equity of €640,449 and a net result of €1.2m. Equity remains stable across the filed financial years (±0.3% per year). The company has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Board 8
Day-to-day management 1
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Bernard LEMARCHAND |
|
| Catherine DAUBY |
|
| Marc BREYER |
|
| Maria HENNES |
|
| Monique SCHMITZ |
|
| PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT |
|
| Philippe GEORIS |
|
| Pierre DETHIER |
|
| Pierre LAFLEUR |
|
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES |
|
| SANTIS GROUP |
|
| Chantal HARDY |
|
Owners and capital
Owners
2 ownersChain of control
Highest known parent: Solidarité. The sources do not say who stands above it.
Owners 2
- 100%
-
100%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- SANTIS GROUP 100%
- SANTIS GROUP (BE 0452.186.779) all shares
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.